(−)-6-Chloro-2-[(1-furo[2,3-c]pyridin-5-ylethyl)thio]-4-pyrimidinamine, PNU-142721, a New Broad Spectrum HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor
- 1 April 1998
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (9) , 1357-1360
- https://doi.org/10.1021/jm9801049
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Section Reviews; Anti-infectives: Section Review Anti-infectives: Therapeutic potential of nonnucleoside reverse transcriptase inhibitors in the treatment of HIV infectionExpert Opinion on Investigational Drugs, 1996
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance developmentMedicinal Research Reviews, 1996
- [25] Analysis of inhibition of retroviral reverse transcriptasePublished by Elsevier ,1996
- Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase InhibitorsJournal of Medicinal Chemistry, 1994
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs)Expert Opinion on Investigational Drugs, 1994
- A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.Proceedings of the National Academy of Sciences, 1993
- Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.Proceedings of the National Academy of Sciences, 1993
- Novel pyrimidine and 1,3,5-triazine hypolipemic agentsJournal of Medicinal Chemistry, 1984